|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Dasatinib plus capecitabine (Cap) for progressive advanced breast cancer (ABC):Phase Ⅰ study CA180004显示文摘 | Somlo G Atzori F Strauss L | 2009 | J Clin Oncol (Meeting Abstracts)2009，27，： | 1 |
| 2 | Molecular genetics and mechanism of autosomal dominant polycystic kidney disease显示文摘 | Wu G Somlo S | 2000 | Mol G enet Metab2000，69，1： | 1 |
| 3 | Renaming 'Chemobrain' 显示文摘 | Hurria A Somlo G Ahles T | 2007 | Cancer Invest2007，25，： | 1 |
| 4 | Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory,and stage IV breast cancer,using a novel detection technology显示文摘 | SOMLO G LAU S K FRANKEL P | 2011 | Breast Cancer Res Treat2011，128，1： | 1 |
| 5 | Prognostic indicators and sur-vival in patients with stage IIIB inflammatory breast carcinoma af- ter dose-intense chemotherapy 显示文摘 | Somlo G Frankel P Chow W | 2004 | Clin Oncol2004，22，10： | 1 |
| 6 | Adaptive lightweight text filte- ring 显示文摘 | SOMLO G HOWE A | 2001 | Proc Lecture Notes in Computer Science2001，，2189： | 1 |
| 7 | Esthetic recon-struction after mastectomy for inflammatory breast cancer: is itworthwhile? 显示文摘 | CHIN P L ANDERSEN J S SOMLO G | 2000 | J Am Coll Surg2000，190，3： | 1 |
| 8 | Identification of F-box/LLR-repeated protein 17 as potential useful biomarker for breast cancer therapy显示文摘 | Zhou BS Somlo G | 2008 | Cancer Genomics Proteomics2008，5，34： | 1 |
| 9 | Oxidative DNA base modifications in peripheral blood mononuclear cells of patients treated with high-dose infusional doxorubicin 显示文摘 | DOROSHOW J H SYNOLD T W SOMLO G | 2001 | Blood2001，97，9： | 1 |
| 10 | A phase I/lI prospective,sin- gle arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage 1V HER-2 positive metastatic breast cancer显示文摘 | Somlo G Martel CL Lau SK | 2012 | Breast Canc- er Res Treat2012，131，3： | 1 |
| 11 | Pharmacogenetic analysis of paclitaxel transport and metabolism genes in breast cancer显示文摘 | Marsh S Somlo G Li X | 2007 | Pharmacogenomics J2007，7，5： | 1 |
| 12 | Recombinant human thrombopoietin in combination with gTanulocyte colony - stimulating factor enhances mobilization of peripheral blood progenitor ceils, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high - dose chemotherapy 显示文摘 | Somlo G Sniecinski I ter Veer A | 1999 | Blood1999，93，9： | 1 |
| 13 | Fibroblast growth factor receptor 3 inhibition by short hairpin RNAs leads to apoptosis in multiple myeloma显示文摘 | Zhu L Somlo G Zhou B | 2005 | Mol Cancer Ther2005，4，5： | 1 |
| 14 | Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy显示文摘 | Somlo G Sniectnski I ter Veer A | 1999 | Blood1999，93，： | 1 |
| 15 | NCCN Breast Cancer ClinicalPractice Guiddiues Panel显示文摘 | EC Smith M L Somlo G | 2009 | Natl Compr Cane Netw2009，7，2： | 1 |
| 16 | FZD7 has a critical role in cell proliferation in triple negative breast cancer 显示文摘 | Yang L Wu X Wang Y Zhang K Wu J Yuan YC Deng X Chen L Kim CC Lau S Somlo G Yen Y | 2011 | Oncogene2011，30，： | 1 |
| 17 | De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer显示文摘 | Wu X Somlo G Yu Y | 2012 | J Transl Med2012，10，： | 1 |
| 18 | Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory,and stage IV breast cancer,using a novel detection technology显示文摘 | Somlo G Lau S K Frankel P | 2011 | Breast Cancer Res Treat2011，128，1： | 1 |
| 19 | Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma:a California Cancer Consortium trial显示文摘 | Somlo G Lashkari A Bel amy W | | 0，，04： | 1 |
| 20 | A phaseⅠ/Ⅱprospective,single arm trial of gefitinib,trastuzumab,and docetaxel in patients with stageⅣHER-2 positive metastatic breast cancer显示文摘 | Somlo G Martel CL Lau SK | 2012 | Breast Cancer Res Treat2012，131，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员